InspireMD 

$1.1
41
-$0.07-5.98% Tuesday 20:00

Statistics

Day High
1.18
Day Low
1.02
52W High
2.79
52W Low
1.1
Volume
573,551
Avg. Volume
-
Mkt Cap
46.61M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

11AugExpected
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q4 2025
Q1 2026
Next
-0.26
-0.22
-0.18
-0.14
Expected EPS
-0.2
Actual EPS
N/A

Financials

-456.63%Profit Margin
Unprofitable
2019
2020
2021
2022
2023
2024
14.02MRevenue
-64.01MNet Income

Analyst Ratings

3Average Price Target
The highest estimate is 3.00.
From 1 ratings within the last 6 months. This is not an investment recommendation.
Buy
100%
Hold
0%
Sell
0%

People Also Follow

This list is based on the watchlists of people on Stock Events who follow NSPR. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Abbott Laboratories
ABT
Mkt Cap155.82B
Abbott Laboratories competes with InspireMD in the cardiovascular device market, particularly in stents and vascular products.
Boston Scientific
BSX
Mkt Cap83.97B
Boston Scientific Corporation offers a wide range of medical devices including those for interventional cardiology, competing directly with InspireMD's stent products.
Medtronic
MDT
Mkt Cap102.71B
Medtronic plc provides medical devices for various healthcare needs, including cardiac and vascular therapies, directly competing with InspireMD's offerings.
Staar Surgical
STAA
Mkt Cap1.35B
STAAR Surgical Company specializes in implantable lenses and delivery systems, competing in the broader market of medical devices for cardiovascular and related conditions.
Johnson & Johnson
JNJ
Mkt Cap546.9B
Johnson & Johnson, through its medical device segment, competes across multiple areas including the manufacture of stents, directly challenging InspireMD.
Stryker
SYK
Mkt Cap112.88B
Stryker Corporation offers products in orthopaedics, medical and surgical, and neurotechnology and spine, which includes vascular technologies competing with InspireMD.
Edwards Lifesciences
EW
Mkt Cap48.42B
Edwards Lifesciences Corporation specializes in heart valves and hemodynamic monitoring, competing in the cardiovascular market alongside InspireMD.
Zimmer Biomet
ZBH
Mkt Cap16.05B
Zimmer Biomet Holdings, Inc. competes in the manufacture of medical devices for musculoskeletal healthcare, which includes vascular and related products.
Integra Lifesciences
IART
Mkt Cap830.03M
Integra LifeSciences Holdings Corporation offers products in neurosurgery, surgical instrumentation, and orthopedics, indirectly competing with InspireMD in the broader medical device market.
Globus Medical
GMED
Mkt Cap12.39B
Globus Medical, Inc. focuses on musculoskeletal solutions, including innovative spinal and orthopedic implants, competing in the medical device market that also covers vascular health solutions.

About

InspireMD, Inc., a medical device company, focuses on the development and commercialization of proprietary MicroNet stent platform technology for the treatment of vascular and coronary diseases in Europe, Latin America, the Middle East, and Asia Pacific. The company offers CGuard carotid embolic prevention system for use in carotid artery applications; and MGuard Prime embolic protection systems for use in patients with acute coronary syndromes, notably acute myocardial infarction, and saphenous vein graft coronary interventions, as well as bypass surgery. It is also developing PVGuard, a MicroNet mesh sleeve and self-expandable stent for use in peripheral vascular applications. The company sells its products through local distributors. InspireMD, Inc. was founded in 2005 and is headquartered in Tel Aviv-Yafo, Israel.
Show more...
CEO
Mr. Marvin L. Slosman
Employees
85
Country
United States
ISIN
US45779A8466

Listings

0 Comments

Share your thoughts

FAQ

What is InspireMD stock price today?
The current price of NSPR is $1.1 USD — it has decreased by -5.98% in the past 24 hours. Watch InspireMD stock price performance more closely on the chart.
What is InspireMD stock ticker?
Depending on the exchange, the stock ticker may vary. For instance, on exchange InspireMD stocks are traded under the ticker NSPR.
Is InspireMD stock price growing?
NSPR stock has fallen by -3.51% compared to the previous week, the month change is a -26.17% fall, over the last year InspireMD has showed a -56.35% decrease.
What is InspireMD market cap?
Today InspireMD has the market capitalization of 46.61M
When is the next InspireMD earnings date?
InspireMD is going to release the next earnings report on August 11, 2026.
What were InspireMD earnings last quarter?
NSPR earnings for the last quarter are -0.16 USD per share, whereas the estimation was -0.18 USD resulting in a +11.11% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is InspireMD revenue for the last year?
InspireMD revenue for the last year amounts to 14.02M USD.
What is InspireMD net income for the last year?
NSPR net income for the last year is -64.01M USD.
How many employees does InspireMD have?
As of May 06, 2026, the company has 85 employees.
In which sector is InspireMD located?
InspireMD operates in the Health & Wellness sector.
When did InspireMD complete a stock split?
The last stock split for InspireMD was on April 27, 2021 with a ratio of 1:15.
Where is InspireMD headquartered?
InspireMD is headquartered in Miami, United States.